Details for New Drug Application (NDA): 019593
✉ Email this page to a colleague
The generic ingredient in ZANTAC IN PLASTIC CONTAINER is ranitidine hydrochloride. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for 019593
| Tradename: | ZANTAC IN PLASTIC CONTAINER |
| Applicant: | Pai Holdings Pharm |
| Ingredient: | ranitidine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/100ML | ||||
| Approval Date: | Dec 17, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/ML | ||||
| Approval Date: | Sep 27, 1991 | TE: | RLD: | No | |||||
Expired US Patents for NDA 019593
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,128,658 | ⤷ Start Trial |
| Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | 4,128,658 | ⤷ Start Trial |
| Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,128,659 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
